“…These approaches are undergoing rapid developments, allowing establishment of human organoids from adult/fetal human liver or pluripotent stem cells and modeling different liver diseases. 68 , 69 , 70 , 71 Different types of liver organoid models from mice, human beings, dogs, and cats now are available for several monogenic liver diseases such as Alagille syndrome, cystic fibrosis, primary sclerosing cholangitis, Wilsons disease, HBV infection, steatosis, or liver cancer, among others. 72 , 73 , 74 , 75 , 76 , 77 , 78 The generation of organoids from adult patient liver tissues also retains the genetic background of the individual patient, thus creating patient-specific disease models and enabling in-depth investigations of pathogenesis mechanisms underlying genetic diseases and cancer.…”